Beyond Injection: HTP Screening driven Oral Peptide Delivery

Injectable administration remains the standard for most peptide therapeutics, largely due to their limited oral bioavailability. Join Thomas in reviewing the current limitations and advancements in oral peptide delivery, the challenges of transitioning from liquid to solid dosage formulations, and an industry perspective on species-related intestinal absorption and large animal-to-human translatability using porcine models.